Expression of a functional single-chain antibody via Corynebacterium pseudodiphtheriticum
Authors:
- 6 March 2008
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 27 (7) , 617-622
Abstract
Antibody-based therapeutics are effective against conditions ranging from acute infections to malignancy. They may prove crucial in combating bioterrorism and responding to drug-resistant and emerging pathogens. At present the cost of producing therapeutic monoclonal antibodies is between $1,000 to $6,000 per gram. The need to administer antibodies parenterally at frequent intervals further drives the cost of this treatment. Here we present an antibody delivery system, termed paratransgenesis, with the potential to overcome these limitations. The paratransgenic approach involves genetically transforming a commensal or symbiont bacterium to express foreign molecules that target pathogens. We describe transformation of Corynebacterium pseudodiptheriticum, a commensal bacterium found in the human respiratory tract, to express a murine single-chain antibody binding progesterone. The antibody was functional and bound specifically to progesterone in a concentration-dependent manner. This marker antibody system is the precursor to development of expression systems producing recombinant humanized single-chain antibodies. Studies are in progress evaluating fitness, transgene stablility, and pathogenecity of the genetically engineered C. pseudodiptheriticum. We anticipate developing a repertoire of expressed molecules targeting infectious agents and surface epitopes of pulmonary mass lesions. If expression systems for anti-pathogen molecules in C. pseudodiptheriticum and other respiratory commensal bacteria can be optimized, these bacteria have the potential for a range of therapeutic and prophylactic applications.Keywords
This publication has 18 references indexed in Scilit:
- An anti-HIV microbicide engineered in commensal bacteria: secretion of HIV-1 fusion inhibitors by lactobacilliAIDS, 2006
- Engineered VaginalLactobacillusStrain for Mucosal Delivery of the Human Immunodeficiency Virus Inhibitor Cyanovirin-NAntimicrobial Agents and Chemotherapy, 2006
- Toward a live microbial microbicide for HIV: Commensal bacteria secreting an HIV fusion inhibitor peptideProceedings of the National Academy of Sciences, 2005
- The challenge of emerging and re-emerging infectious diseasesNature, 2004
- Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4Proceedings of the National Academy of Sciences, 2003
- Corynebacterium pseudodiphtheriticum: an easily missed respiratory pathogen in HIV-infected patientsDiagnostic Microbiology and Infectious Disease, 1999
- Phage-display technology – finding a needle in a vast molecular haystackCurrent Opinion in Biotechnology, 1999
- Functional expression of a single-chain anti-progesterone antibody fragment in the cytoplasm of a mutantEscherichia coilNucleic Acids Research, 1995
- Half-life of polyreactive antibodiesJournal of Clinical Immunology, 1994
- Medical Applications of Single-Chain AntibodiesInternational Reviews of Immunology, 1993